3Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 1988, 37 (12).1595-1607.
4Stem ME Diabetes and cardiovascular disease The"common soil" hypothesis. Diabetes, 1995, 44 (4):369-374.
5World Health Organization. Diagnosis and classification of diabetes mellitus and its complication: report of a WHO consultion. Part 1 : diagnosis and classification of diabetes mellitus. Geneva: WHO Press, 1999. 169-175.
1Wilson PW, Kannel WB, Sibershatz H, et al. Clustering of metabolic factors and coronary heart disease. Arch Intern Med,1999, 159: 1104-1109.
2lsomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care,2001, 24: 683-689.
3Ridker PM, Burning JE, Cook NR, et al. C-reactive protein,the metabolie syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14719 initially healthy American women. Circulation,2003, 107: 391-397.
4World Health Organization. Definition, diagnosis and classifica-ion of diabetes mellitus and its complications. Report of a WHO consultation, Part 1: Diagnosis and classification of diabetes mellitus. WHO: Geneva, 1999.
5National Institutes of Health, Third report of the national cholesterol education program expert panel on detection, evaluation,and treatment of high blood cholesterol in adults (Adult treatment Panel Ⅲ). Executive summary. Bethesda, MD, National Institutes of Health, National Heart, Lung and Blood Institute,2001 (NIH publ, no. 01-3670).
6Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care,2003, 26:575 581.
7Reaven GM. Role of insulin resistance in human disease. Diabetes,1988,37(12):1595--1607.
